drugset / Trial / NCT02541526

Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia

NCT02541526

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate tolerability, acceptability and potential efficacy of 4 months of maintenance treatment with Mirtazapine as compared to placebo for patients with co-occurring amphetamine-type stimulant and opioid dependence (COATS) receiving buprenorphine maintenance treatment (BMT) in Kota Bharu.

Timeline

Start
2013-05
Primary completion
2017-01
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirtazapine Other / unclassified 30 mg Oral